Therapy-Related Acute Myeloid Leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after Hemophagocytic Lymphohistiocytosis

Secondary hemophagocytic lymphohistiocytosis in pediatric patients: a single center experience and factors that influenced patient prognosis

(2019) Melahat Melek Oguz et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL–USP2 fusions

(2019) Claus Meyer et al.   LEUKEMIA

The MLL recombinome of acute leukemias in 2017

(2017) C Meyer et al.   LEUKEMIA

Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature

(2016) Hua Pan et al.   BMC Pediatrics

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study

(2015) Lene Sofie Granfeldt Østgård et al.   JOURNAL OF CLINICAL ONCOLOGY

Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias

(2015) Thomas Burmeister et al.   LEUKEMIA RESEARCH

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols

(2012) T Kalina et al.   LEUKEMIA

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor

(2012) Sachiko Ezoe   International Journal of Environmental Research and Public Health